Comparing DDAVP vs Humate-P
DDAVP (desmopressin) | Humate-P (antihemophilic factor/von willebrand factor) |
|
---|
DDAVP (desmopressin) | Humate-P (antihemophilic factor/von willebrand factor) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Diabetes Insipidus, Primary Nocturnal Enuresis, von Willebrand Disease, Hemophilia A. DDAVP may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for von Willebrand Disease, Hemophilia A. Humate-P may also be used for purposes not listed in this medication guide. |
Related suggestions von Willebrand Disease
Hemophilia A
Popular comparisons
|
|||||||||||||||
More about DDAVP (desmopressin) | More about Humate-P (antihemophilic factor/von willebrand factor) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
DDAVP has an average rating of 9.7 out of 10 from a total of 9 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Humate-P has an average rating of 10.0 out of 10 from a total of 3 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all DDAVP side effects |
View all Humate-P side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
N/A |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all DDAVP prices |
View all Humate-P prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Other desmopressin brands include: DDAVP Nasal, DDAVP Rhinal Tube, Minirin, Nocdurna | Other antihemophilic factor/von willebrand factor brands include: Alphanate, Dried Factor VIII Fraction Type 8Y, Wilate | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
4 hours |
24 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 122 drugs are known to interact with DDAVP:
|
A total of 9 drugs are known to interact with Humate-P:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
|||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.